Farmadol

Quick links to important sections

Medically reviewed

Marina Burgos

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Farmadol

What is Farmadol?

Farmadol is a pharmaceutical monocomponent preparation containing the active ingredient Acetaminophen, scientifically known as Paracetamol. It is formally classified as both an analgesic and an antipyretic, placing it within the therapeutic group of Non-Opioid Analgesics and the chemical class of Para-aminophenol derivatives. This compound is a synthetic compound whose efficacy in managing common symptoms is established in pharmacology, defining its role as a key symptomatic treatment.

Identity, Composition, and Purpose

The general purpose of Farmadol is the symptomatic management of pain relief and the functional reduction of fever. Acetaminophen is recognized as an essential medicine due to its reliable pain-relieving and fever-reducing properties. This status indicates that the medicine is considered vital for public health in managing common symptoms of pain and fever.

Farmadol is widely accessible as an Over-the-counter (OTC) medication and comes in various pharmaceutical preparations, including specialized oral tablets, syrup formulations often used for pediatric care, and suppositories, allowing for oral or rectal routes of administration. Acetaminophen helps lower fever by acting on the temperature-regulating center in the brain. This central action ensures Farmadol offers targeted symptomatic relief from discomfort often associated with minor aches or transient febrile conditions.

What side effects are possible with Farmadol?

Possible Side Effects and Safety Information

Farmadol (Acetaminophen/Paracetamol) is classified by regulatory authorities based on a safety profile that documents potential adverse reactions, particularly concerning rare but serious events affecting specific organ systems.

Adverse Reaction Classification

Adverse effects are categorized within official regulatory documents according to System-Organ Classes (SOCs). The systems primarily associated with documented adverse reactions are the Hepatobiliary Disorders, Immune System Disorders, Blood and Lymphatic System Disorders, and Skin and Subcutaneous Tissue Disorders.

Classification Examples of Reactions
Rare (1/10,000 to 1/1,000) Blood dyscrasias (e.g., thrombocytopenia, agranulocytosis), liver function abnormalities, non-severe hypersensitivity reactions.
Frequency Not Known Severe Cutaneous Adverse Reactions (SCARs), including Stevens-Johnson Syndrome (SJS) and Toxic Epidermal Necrolysis (TEN).

Serious Safety Concerns

The regulatory labeling specifically highlights severe, clinically significant adverse reactions, including Acute Liver Failure, which is a primary concern associated with high cumulative doses or overdose. Rare, severe allergic responses such as anaphylaxis are also explicitly documented in official safety information.

Population and Exposure Safety Notes

The risk profile is formally noted to change based on pre-existing conditions and duration of use. The medication is contraindicated in cases of severe hepatic impairment. Caution is advised for individuals with severe renal impairment and for chronic alcohol users due to an increased risk of hepatotoxicity. Furthermore, prolonged, high-dose exposure is associated with a risk of developing certain forms of kidney damage, such as analgesic nephropathy.

Overdose and Emergency Response

Overdose and When to Seek Help

The regulatory documentation for Farmadol (Acetaminophen/Paracetamol) strictly defines the manifestations of overdose and the mandatory emergency actions required. The principal risk documented in official labeling is dose-dependent hepatotoxicity (severe liver damage), which can progress to potentially fatal hepatic necrosis.

Overdose symptoms are often non-specific in the first 24 hours, commonly including nausea, vomiting, anorexia, diaphoresis (sweating), and general malaise. These early signs do not reliably predict the severity of the ultimate liver injury. Later manifestations may include abdominal pain and clinical signs of hepatic failure.

Immediate medical attention is mandatory for all suspected or known overdoses, regardless of whether initial symptoms are present. Government guidance requires that emergency services or a Poison Control Center (PCC) be contacted immediately. Hospital monitoring and assessment of plasma drug concentrations are necessary.

Management procedures described in official documents include the administration of the specific antidote, N-acetylcysteine (NAC), along with supportive measures such as gastric lavage or activated charcoal to limit absorption. Regulatory information also notes that patients with pre-existing hepatic impairment or chronic alcohol dependence may face an increased risk of severe toxicity.

Therapeutic Uses of Farmadol

What Farmadol Treats: Main Uses and Benefits

Farmadol is commonly used for symptomatic relief across two primary therapeutic domains, assists with managing distressing symptoms, and offers supportive assistance during episodes of discomfort. The medication is commonly used to help with mild to moderate pain and to reduce fever.


Therapeutic Focus and Symptom Relief

Farmadol is commonly used for managing diverse acute and episodic pain symptoms that create noticeable interference with daily stability. This includes common manifestations such as headaches, toothache, muscle aches (myalgia), and cyclical discomfort like dysmenorrhea (menstrual cramps).

The medication is also considered relevant in clinical settings marked by pyrexia (fever), often associated with seasonal illnesses like the common cold and influenza. It is applied in scenarios where additional management of discomfort is required, such as following minor medical or dental procedures, to help address functional strain.

“This application provides symptomatic relief that supports general well-being during symptomatic phases.”

Relief for Episodic Discomfort: Farmadol supports patients during difficult episodes by easing distress and contributes to improved day-to-day comfort when symptoms are more noticeable.

Regulatory References

  1. NIH MedlinePlus Drug Information overview

Eligibility and Restrictions for Use

Eligibility Map: Official Regulatory Information

Official regulatory documentation defines eligibility for Farmadol (Acetaminophen/Paracetamol) by establishing strict exclusions for certain populations and conditional use for others.

Eligibility Scope Status as Defined in Labeling
Populations for whom use is Contraindicated Known hypersensitivity to the drug or any component, severe active liver disease, or concurrent use with any other acetaminophen-containing product (to prevent overdose).
Populations for whom use is Allowed Adults, adolescents, and children meeting specific minimum age and weight thresholds.

Condition-Based and Age-Related Restrictions

Eligibility is restricted or conditional for groups with factors that increase the risk of liver toxicity. Use requires caution in patients with severe renal impairment, existing hepatic impairment (non-severe), and individuals with a history of chronic alcohol consumption or risk factors like chronic malnutrition.

Age-Related Rules: Use in children is permitted but restricted by minimum age and weight requirements, and generally requires consulting a healthcare provider for infants under a specified threshold (e.g., three months).

Physiological States: Use during pregnancy is permitted when clinically necessary, under the condition of using the lowest effective dose for the shortest duration. The medicine is generally considered compatible with breastfeeding at recommended doses. The regulatory basis for these rules is drawn from agencies including the FDA, EMA, and Health Canada, focusing on patient safety and risk mitigation.

What should I know about interactions with other medicines?

Farmadol (acetaminophen/paracetamol) can interact with several other medications, which may affect its safety or effectiveness. It is crucial to consult a healthcare professional before combining Farmadol with any other product.

Potential Drug Interactions

Type of Medicine Potential Interaction and Risk Monitoring/Advice
Other Paracetamol-Containing Products (e.g., cold/flu remedies, combination painkillers) Increased risk of liver damage and overdose. The daily maximum dose of paracetamol (4 grams for adults) can be easily exceeded. Do not take Farmadol with any other product that contains paracetamol. Check all medicine labels carefully.
Blood Thinners (Anticoagulants), particularly Warfarin Regular, long-term use of paracetamol may increase the risk of bleeding by enhancing the effect of warfarin. Close monitoring of the International Normalized Ratio (INR) is required if taken regularly. Consult a doctor.
Enzyme-Inducing Medicines (e.g., Phenytoin, Carbamazepine, Phenobarbital, Rifampicin) These medicines can increase the metabolism of paracetamol, potentially reducing its effectiveness and increasing the risk of liver toxicity. A healthcare provider may need to adjust the dosage or recommend an alternative pain reliever.
Cholestyramine (used for cholesterol/itching) Can reduce the absorption of paracetamol, potentially lowering its effectiveness. Take Farmadol at least one hour before or four hours after taking Cholestyramine.

Other Important Interactions

Alcohol consumption, especially chronic heavy use, significantly increases the risk of severe liver damage when taking Farmadol. Patients with a history of alcohol misuse or chronic liver disease must exercise extreme caution and should only use the product under medical supervision.

Mechanism of Action

mu-Opioid Receptor Agonism and Monoamine Modulation

Farmadol acts through a multimodal mechanism, beginning with Tramadol (and its active metabolite) targeting mu-Opioid Receptors within the central nervous system (CNS). This agonistic interaction inhibits the release of excitatory neurotransmitters from nociceptive neurons, resulting in the modulation of pain signal propagation. Simultaneously, Tramadol blocks the reuptake of norepinephrine and serotonin at the spinal cord, increasing their synaptic concentration. This enhances the activity of the descending pain inhibitory pathway, contributing to the overall suppression of ascending nociceptive signals.

Central Prostaglandin Synthesis Modulation

Paracetamol (Acetaminophen) contributes to the effect by acting in the CNS to modulate the Cyclooxygenase (COX) enzymes, inhibiting the synthesis of prostaglandins, primarily PGE2, in the hypothalamus. This molecular action results in the modulation of the body's thermoregulatory set-point. The complementary actions across these distinct pathways facilitate a comprehensive physiological modulation of both nociceptive and thermoregulatory signaling patterns.

Dosage and Administration Information

Farmadol (Acetaminophen/Paracetamol) administration is governed by explicit instructions which define the route, dose, frequency, and patient-specific adjustments to ensure appropriate use.

Official Administration Guidelines

The medicine is officially approved for oral, rectal (suppositories), and intravenous (IV) infusion routes, with administration dependent on the specific formulation being used. Dosage is typically administered on an as-needed basis, with immediate-release forms given every 4 to 6 hours. A minimum interval of at least four hours between doses must be strictly observed.

Administration Rule Labeled Instruction (Examples)
Standard Adult Dose 650 mg to 1,000 mg per single dose.
Maximum Total Daily Dose Must not exceed 4,000 mg (4 grams) in 24 hours from all sources.
Population Adjustment Dose reduction or prolonged interval (e.g., 500 mg every 8 hours) is required for severe renal impairment.
Specific Handling Extended-release tablets must be swallowed whole (do not crush or chew). IV infusion must be administered over a 15-minute period.

The medication may be taken with or without food. If a dose is missed, the general protocol is to skip the missed dose and resume the regular dosing schedule; double dosing is not permitted. Treatment for self-medication is generally restricted to short-term use, such as no more than 10 days for pain, unless otherwise directed.

Recent Clinical Evidence

Farmadol: Recent Clinical Evidence

Evidence for Use in Managing Fever (Pyrexia)

Research has explored studies of Farmadol in conditions characterized by temporary physiological imbalance, specifically fever (pyrexia). Studies conducted on this topic primarily involve Randomized Controlled Trials (RCTs) and comprehensive Meta-analyses. Researchers primarily monitored outcomes related to systemic or functional imbalance by measuring changes in body temperature over defined time intervals. Studies reported patterns observed in the observed populations, with a focus on acute symptomatic action within 24 to 48 hours. Research into certain complex or severe clinical contexts remains less characterized.

Evidence for Use in Managing Mild to Moderate Pain

Farmadol was studied in research contexts involving periods of heightened symptoms, specifically episodic mild to moderate pain. The evidence base includes extensive RCTs and Systematic Reviews which researched short-term symptom changes. Studies explored outcomes related to physical discomfort by measuring patient-reported outcomes describing perceived discomfort. The research describes patterns related to symptomatic changes observed during the study period, often including single-dose assessments or brief, short-term treatment periods.

Research on Specific Episodic Pain Types

Research explored Farmadol in the context of episodes where symptoms become more noticeable, such as headaches, toothache, and dysmenorrhea (menstrual cramps). Studies monitored outcomes capturing phases of heightened symptom activity, such as pain-free rates and changes in pain severity. Research provides context on short-term changes for these conditions marked by functional limitations.

Key Limitations and Uncertainties in the Evidence

Research examining studies of Farmadol is largely focused on short-term symptomatic management. Follow-up durations were limited across many trials, particularly those for acute pain management. Long-term effects or the durability of symptomatic changes are not fully established by the existing evidence base. Furthermore, the research is limited for certain subgroups, and data for populations like older adults or those with complex comorbid conditions remain insufficient compared to the general adult population studies.

Key Studies & References

  1. World Health Organization Essential Medicines List
  2. Acetaminophen Drug Information (NIH/MedlinePlus)
  3. Acetaminophen: Mechanism of Action, Uses, and Toxicity (NIH/StatPearls Review)

Frequently Asked Questions (FAQ)

Common questions about Farmadol (FAQ)

Q: What is the main thing Farmadol is used for?

Official product information states that Farmadol is indicated for the short-term management of acute pain. This use is generally reserved for pain that is severe enough to require an opioid component and when other non-opioid options are not suitable or adequate.


Q: Is Farmadol a type of painkiller?

Yes, regulatory sources describe Farmadol as a combination medicine used for pain management. It contains both acetaminophen and an opioid-like substance. The combination works through multiple mechanisms to help suppress pain signals in the body.


Q: What makes Farmadol different from over-the-counter pain relief?

Farmadol is fundamentally different because it contains an opioid-like component, tramadol. This component requires a prescription and is classified as a Schedule IV controlled substance. This classification reflects the potential for abuse and physical dependence, which is not associated with typical over-the-counter pain relievers.


Q: How quickly does Farmadol start to work?

The official pharmacokinetic data indicates that the pain-relieving effects of the fast-acting formulation typically begin within 30 to 60 minutes after a dose is taken. The effects usually build up to a peak within a few hours.


Q: How long do the effects of Farmadol typically last?

Regulatory guidance suggests that the fast-acting formulation is typically administered every 4 to 6 hours as needed to maintain pain relief. The therapeutic effect often reaches its peak within two to three hours after administration.


Q: Can Farmadol be taken every day?

Official labeling specifies that the use of this product for the management of acute pain should be limited to 5 days or less. If ongoing pain relief is required beyond this period, it requires re-evaluation by a healthcare professional.


Q: Are there any common foods or drinks that interact with Farmadol?

Regulatory warnings emphasize the severe risk of using this medication with alcohol. Combining the two substances can increase the risk of serious side effects, including profound sedation, dangerous respiratory depression (slowed or stopped breathing), coma, and death.


Q: What are the most commonly reported side effects of Farmadol?

According to official adverse event data, the most commonly reported side effects include drowsiness, dizziness, nausea, vomiting, and constipation. Some people also report increased sweating or decreased concentration/coordination while using this product.


Q: Do the side effects of Farmadol usually go away after a few days?

Official patient information notes that the intensity of certain side effects may lessen over time. Side effects like nausea, vomiting, and drowsiness may decrease after the medication has been used regularly for a while.


Q: Is Farmadol safe for people over 65?

Regulatory documents note that the use of Farmadol in patients over 65 years of age carries increased risks, including heightened risk of respiratory depression. For this reason, official guidance suggests that a healthcare professional may need to prescribe a lower dosage or increase the time between doses, especially for individuals with reduced liver or kidney function.


Q: Can teenagers use Farmadol?

Official regulatory information specifies that the product is contraindicated (should not be used) for children under 12 years of age. It is also contraindicated for anyone under 18 years old who is recovering from a tonsillectomy or adenoidectomy procedure.


Q: Are there warnings about using Farmadol during pregnancy?

Yes, official warnings address use during pregnancy. Prolonged or chronic use of this product while pregnant may result in the infant developing Neonatal Opioid Withdrawal Syndrome (NOWS). This condition can be life-threatening if not immediately recognized and treated by medical professionals.


Q: What are the serious safety warnings associated with Farmadol?

Regulatory documents include multiple Boxed Warnings to highlight the most serious safety risks. These risks include addiction, abuse, and misuse; life-threatening respiratory depression (dangerously slowed breathing); and severe liver damage (hepatotoxicity) from the acetaminophen component.


Q: Does Farmadol make you sleepy or affect driving?

Yes, official safety information states that the medicine may cause drowsiness, dizziness, and decreased concentration. Because of these effects, the regulatory labeling contains warnings regarding the operation of vehicles or heavy machinery.


Q: Why is it important to know who cannot use Farmadol?

Regulatory information regarding contraindications exists because using the medicine under certain conditions poses serious safety risks. These risks can include life-threatening complications such as severe respiratory depression (when breathing slows dangerously) or a severe, systemic allergic reaction (hypersensitivity).


Q: Can Farmadol affect my blood pressure?

Regulatory documents state that a rare, serious side effect may include effects on blood pressure. This could manifest as severe hypotension (abnormally low blood pressure), including a sudden drop in blood pressure when moving from a sitting or lying position (orthostatic hypotension).


Q: Is Farmadol addictive?

Yes, Farmadol contains tramadol, an opioid-like substance, and carries a Boxed Warning about the risk of addiction, abuse, and misuse. Because of this potential, the product is classified as a Schedule IV controlled substance.


Q: Is it normal to feel a bit dizzy after taking Farmadol?

According to official adverse event data, dizziness and lightheadedness are listed as common side effects that can occur while taking this medication. Unexpected or severe symptoms should be brought to the attention of a healthcare professional.


Q: Why is Farmadol prescribed only for certain conditions?

The official prescribing information states that this product is reserved for use when alternative, non-opioid treatments are not tolerated or are otherwise inadequate. This restriction is due to the potential risks of addiction, abuse, and misuse associated with the opioid-like component.


Q: What should I do if I think I'm having a rare side effect?

Official warnings emphasize that very serious side effects, such as trouble breathing, fainting, or signs of a severe allergic reaction, require immediate medical attention. If you believe you are experiencing a rare or life-threatening adverse event, regulatory guidance requires immediate discontinuation of the medication and the seeking of emergency medical assistance if such severe adverse events are suspected.


Q: Can Farmadol cause stomach upset?

Yes, official data from clinical studies reports that certain gastrointestinal issues are common. Nausea, vomiting, and constipation are listed among the frequently reported side effects.


Q: What is the purpose of the black box warning on Farmadol, if it has one?

Farmadol carries several Boxed Warnings (the FDA's most stringent warning). These warnings are mandated in regulatory documents to ensure that patients and prescribers are fully aware of the most serious safety risks, such as the potential for addiction, fatal respiratory depression, and severe liver damage.


Q: Is Farmadol a controlled substance?

Yes, the tramadol component of this medication is designated as a Schedule IV controlled substance under federal law. This classification signifies that the drug has an accepted medical use but also carries a risk of dependence and misuse.


Q: What happens when Farmadol is taken with herbal supplements?

Regulatory warnings advise caution regarding supplements that can affect the body's serotonin levels. St. John's wort is specifically cited in official documents as a supplement that can interact with the medicine, increasing the potential for a rare but serious condition called Serotonin Syndrome.


Q: Has the FDA (or similar agency) given Farmadol any special safety alerts?

Yes, official regulatory agencies, such as the FDA, have issued several serious safety alerts regarding this product. These alerts are formalized through Boxed Warnings and other cautions in the official documentation, highlighting risks such as addiction and life-threatening respiratory depression.


Q: Does Farmadol have a risk of allergic reactions?

Yes, official information states that the product can cause serious and potentially life-threatening allergic reactions, including anaphylaxis (a severe, whole-body reaction). The product is formally contraindicated for anyone with a known history of hypersensitivity or severe allergy to its components.


Q: How is Farmadol supposed to be stored?

Regulatory guidance advises that Farmadol should be stored at room temperature, protected from excessive light and moisture. Due to the risk of accidental ingestion and fatal overdose, the product is required to be stored in a secure location that is out of the sight and reach of children and pets.


Q: Why do official sources state Farmadol has certain contraindications?

Official sources state contraindications (reasons why the medicine should not be used) to protect patients from severe adverse events. For instance, using Farmadol while taking an MAOI (Monoamine Oxidase Inhibitor) or if a person has severe respiratory depression could significantly increase the risk of death.


Q: What happens to Farmadol once it's metabolized by the body?

Regulatory clinical pharmacology notes that the tramadol component is processed by specific liver enzymes (CYP2D6 and CYP3A4). This process converts some of the tramadol into an active metabolite (M1), which is responsible for contributing to the pain-relieving effects of the medicine.


Q: Is it okay to stop taking Farmadol suddenly?

Official guidance advises against stopping the medication suddenly on your own. Because of the opioid-like component, abruptly discontinuing treatment can lead to withdrawal symptoms. Any decision to alter the treatment schedule is typically managed by a healthcare professional.


Q: Can Farmadol be crushed or chewed?

Official guidance for certain formulations, such as extended-release tablets, notes the regulatory requirement that they be swallowed whole. Crushing or chewing these types of tablets can cause the rapid release of a dangerously high amount of medicine, which could result in a fatal overdose.


Q: How do doctors monitor the effects of Farmadol?

Regulatory documents advise that patients must be monitored for certain serious risks, particularly respiratory depression (slowed breathing). Monitoring is considered especially important when a patient first starts treatment or after any change in dosage.


Q: Do certain medical conditions prevent me from using Farmadol?

Yes, there are specific medical conditions listed as contraindications that prevent the use of this product. Examples include significant respiratory depression (severe breathing issues), acute asthma, concurrent MAOI use, and known hypersensitivity to the components.

How should Farmadol be stored and disposed of?

Storage and Disposal Requirements

Official regulatory labeling dictates specific conditions for storing and disposing of Farmadol (Paracetamol) to ensure product stability and safety.

Storage Conditions

The medicine must be stored at a temperature not exceeding 30 C and kept protected from both light and moisture. To prevent degradation, certain liquid formulations carry the explicit instruction Do not freeze. The product must be stored in the original packaging and, critically, kept out of the sight and reach of children.

Disposal Instructions

Unused or expired Farmadol must be handled as pharmaceutical waste. Official regulatory guidance advises that medicines must not be disposed of via wastewater or standard household trash. Instead, patients are instructed to dispose of the product in accordance with local requirements, such as utilizing official drug take-back programs.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Farmadol found in:

A-Z Index: